Registering a veterinary medicinal product in the European Union requires submitting a complete technical dossier to the relevant authority, often in more than one language. For companies seeking a Marketing Authorisation (MA) in Portugal or across EU Member States, translation quality is not an administrative formality: it is a regulatory requirement with direct consequences for approval timelines and product launch dates.
What the veterinary registration dossier covers
The registration dossier for a veterinary medicinal product follows the Common Technical Document (CTD) structure defined by Regulation (EU) 2019/6, which came into full application in January 2022. This regulation replaced Directive 2001/82/EC and introduced more detailed documentation requirements.
Documents that typically require translation include:
- Summary of Product Characteristics (SPC/SmPC): the central document of the MA, requiring precise terminological accuracy for each target market language.
- Package leaflet and labelling: mandatory in the official language of each Member State where the product is placed on the market.
- CTD modules 1 to 5: quality reports, non-clinical studies, veterinary clinical trials, safety and efficacy data.
- Risk Management Plan (RMP): where applicable, requires full translation for submission to the EMA or national agencies.
- Residue studies: mandatory for products administered to food-producing animals, with specific toxicology and pharmacology terminology.
In Portugal, the competent authority is the DGAV (Directorate-General for Food and Veterinary Affairs). Centralised procedures covering all Member States are managed by the EMA.
Language and terminology requirements
Translating veterinary regulatory documentation is not the same as translating general medical texts. Three requirements distinguish it and define the level of service needed.
Controlled terminology. The SPC and package leaflet must use terms approved by the regulatory authorities, including veterinary anatomical nomenclature, International Non-proprietary Names (INNs), and target species names. An unrecognised term can trigger a request for clarification or delay approval.
Cross-module consistency. The CTD dossier is composed of independent modules, but terminology must be consistent throughout. Translations produced by different teams without shared glossaries generate inconsistencies that agencies identify during technical review.
Variable source language. Source documentation may be in English, German, French, Spanish, Italian, or other European languages. Less common language pairs (for example, Hungarian-to-Portuguese or Polish-to-Portuguese) require translators with specific training in veterinary or pharmaceutical sciences.
For related regulatory translation requirements, the article on drug labelling translation covers the specific obligations for packaging and package inserts in detail.
Registration procedures and their translation implications
Regulation (EU) 2019/6 provides four main authorisation routes for veterinary medicinal products:
- Centralised procedure (CP): mandatory for certain categories (biotechnology products, new active substances for specific species). The dossier is submitted to the EMA and the resulting MA is valid across all Member States. The SPC and package leaflet must be translated into all 24 official EU languages.
- Mutual recognition procedure (MRP): a reference Member State evaluates the product; other states recognise the decision. Translation is required for each recognising Member State's language.
- Decentralised procedure (DCP): similar to MRP but without a prior MA. Requires linguistic coordination across multiple Member States from the outset.
- National procedure: direct submission to the national authority (DGAV in Portugal) for a product intended for a single national market. The dossier may be submitted in Portuguese or English, depending on the module.
The chosen procedure determines both translation volume and deadlines. In the centralised procedure, volume can be substantial: the veterinary SPC is typically longer than its human medicine equivalent, given the need to specify doses by species, body weight, and indication.
The methodology applied to veterinary regulatory dossiers closely parallels the approach used for translating clinical trial protocols for regulatory submission, where cross-document terminological consistency carries the same level of scrutiny.
Factors that determine cost and turnaround
The translation budget for a veterinary dossier depends on several variables that are worth identifying before requesting a quote:
- Total word count: full CTD dossiers can run to hundreds of thousands of words; quality and safety modules tend to be the most extensive.
- Language pairs: English-to-Portuguese is the most common pair and has a larger pool of qualified specialists; less frequent pairs have lower availability and different lead times.
- Urgency: regulatory windows (responses to questions from the authority, for example) require fast delivery, which means allocating additional team capacity.
- Certification level required: some authorities require certified or attested translation; others accept standard translation accompanied by a company declaration.
- Translation memory assets: if previous dossier versions exist, translation memories reduce the effective volume to translate and improve consistency across versions.
- Formatting: regulatory documents have fixed structures (tables, standardised headings, CTD numbering) that require specialist desktop publishing to maintain visual compliance.
How M21Global supports veterinary medicinal product registration
M21Global has over 20 years of experience in pharmaceutical and regulatory translation, with ISO 17100:2015 certification verified by Bureau Veritas. For veterinary registration dossiers, the Estratégica service tier is the appropriate choice: it involves three linguists (translator, reviewer, and QA reviewer), independent review, and two post-delivery revision rounds. This workflow is designed for high-impact regulatory documentation, where a terminological error can trigger a clarification request or delay the MA.
The team works with validated veterinary and pharmaceutical glossaries, client-specific translation memories, and CAT tools compatible with the most common regulatory formats (Word, XML, eCTD). The service covers all language pairs relevant to European and Portuguese-speaking markets.
For a full overview of M21Global's regulatory and pharmaceutical capabilities, visit the pharmaceutical translation services page. To start a veterinary registration project, request a quote directly through the site.
Related Services
Request a free medical translation quote
- Request a free medical translation quote
- Medical Device Documentation Translation Mdr Compliance
- Translating Clinical Trial Protocols Regulatory Submission
- Drug Labeling Translation
Frequently Asked Questions
Does the veterinary SPC translation need to be certified for DGAV submission?
It depends on the registration procedure. For national procedures, the DGAV may accept standard translation accompanied by a company declaration. For centralised procedures via the EMA, requirements follow the agency's own guidelines. The certification level should be confirmed with the DGAV or the project's regulatory affairs manager before translation begins.
How many languages are required for a centralised veterinary marketing authorisation?
In a centralised procedure managed by the EMA, the SPC and package leaflet must be translated into all 24 official languages of the European Union. English is typically the working language for the technical dossier, but user-facing documents are mandatorily published in every EU language.
What distinguishes veterinary documentation translation from human medicine documentation translation?
Veterinary documentation requires terminology specific to each target species (equine, bovine, porcine, companion animals, and others), species- and weight-dependent dosing information, and residue data for food-producing animals. These elements have no direct equivalent in human medicine documentation and require translators with training in veterinary sciences or animal pharmacology.
Can translation memories from previous dossier versions be reused?
Yes. Translation memories from earlier dossier versions reduce the effective volume to translate, improve terminological consistency, and can shorten delivery times. M21Global maintains client-specific translation memories for recurring regulatory projects.
What is a realistic turnaround for a full CTD module?
Turnaround depends on word count, language pair, and submission urgency. An extensive quality module may require several days with a dedicated team. For projects with fixed regulatory deadlines, additional capacity can be allocated; turnaround should be discussed when requesting a quote.
